Related content

CYP1A1 gene polymorphism and polycystic ovary syndrome

By Esinler Ibrahim   Aktas Dilek   Otegen Umit   Alikasifoglu Mehmet   Yarali Hakan   Tuncbilek Ergul  

Reproductive BioMedicine Online, Vol. 16, Iss. 3, 2008-03 ,pp. : 356-360

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Niemann-Pick C1-Like 1 (NPC1L1) Inhibition and Cardiovascular Diseases

By  

Current Medicinal Chemistry, Vol. 23, Iss. 10, 2016-03 ,pp. : 983-999

Bentham Science Publishers

Access to resources Recommend Favorite

The effect of 3435C>T MDR1 gene polymorphism on rheumatoid arthritis treatment with disease-modifying antirheumatic drugs

By Drozdzik Marek   Rudas Tomasz   Pawlik Andrzej   Kurzawski Mateusz   Czerny Bogusław   Gornik Wanda   Herczynska Magdalena  

European Journal of Clinical Pharmacology, Vol. 62, Iss. 11, 2006-11 ,pp. : 933-937

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacogenetics of irinotecan: A promoter polymorphism of UGT1A1 gene and severe adverse reactions to irinotecan

By Ando Maki   Hasegawa Yoshinori   Ando Yuichi  

Investigational New Drugs, Vol. 23, Iss. 6, 2005-12 ,pp. : 539-545

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacokinetics of tramadol is affected by MDR1 polymorphism C3435T

By Slanař Ondřej   Nobilis Milan   Kvétina Jaroslav   Matoušková Olga   Idle Jeffrey   Perlík František  

European Journal of Clinical Pharmacology, Vol. 63, Iss. 4, 2007-04 ,pp. : 419-421

Springer Publishing Company

Access to resources Recommend Favorite